Our team
Václav Navrátil, Ph.D. – CEO & CTO
Václav is the main inventor of the DIANA technology and currently acts as our CEO and also leads our research and developmental activities. Václav studied biochemistry and theoretical chemistry at the Charles University in Prague and subsequently worked as a research scientist at the IOCB Prague.
Martin Dienstbier, Ph.D. – CFO & COO
Martin facilitated our transition from academia to the industry and is now responsible for our finances and operations. Martin studied molecular biology at the University of Cambridge and then worked as a research fellow at the University of Oxford, followed by the career in management consulting with Boston Consulting Group.
Jiří Schimer, Ph.D.
Head of chemistry
Jiří is our chemistry guru, synthesizing DIANA probes for new targets and leading our medicinal chemistry in drug discovery. Jiří studied biochemistry at the Charles University and worked as a postdoctoral fellow at Georgia Institute of Technology and at IOCB Prague.
Jan Tykvart, Ph.D.
Head of lab operations
Jan leads our laboratory operations and is also instrumental in developing our new R&D projects. Jan studied biochemistry at the Charles University, followed by PhD at IOCB Prague. He then worked as a postdoctoral fellow at the University of Toronto, developing diagnostic applications.
Vincent Messier, Ph.D.
Senior Scientist
Vincent is supporting our drug discovery efforts with his expertise from studying cellular interaction networks using high-throughput techniques. Vincent studied biochemistry at Mcgill University, followed by PhD at the Université de Montréal and Research Associate at the University of Toronto.
Jitka Zemanová
Research Scientist
Clinical diagnostics & Method development
Jakub Hejdánek
Research Scientist
Drug discovery & Pharmacology
Petra Jakab
Office manager
Admin, finances, office operations
Anna Malinová, Ph.D.
Research Scientist
Clinical diagnostics & Drug discovery
Tadeáš Bílek
Junior Research Scientist
Drug discovery & Pharmacology
Silvie Tománková, Ph.D.
Research Scientist
Clinical diagnostics & Method development
Klára Přibyslavská
Research Scientist
Monoclonal antibodies & Method development
Ondřej Smetana, Ph.D.
Research Scientist
Clinical diagnostics & Method development
Supervisory board
Jan Konvalinka (IOCB)
Co-inventor
IOCB representative
Jaromír Zahrádka (I&I Prague)
Technology transfer
IOCB representative
Pavel Brůžek (BTCZ Ventures)
Chairman of the board
Investor representative
Miroslav Tvrzník (BPD Partners)
Investor representative